GBL Acquires Rayner, Global

GBL (Groupe Bruxelles Lambert) has acquired Rayner, a global leader in cataract surgery solutions, for $500.0 million.

This transaction marks a significant corporate acquisition, bringing Rayner under the ownership of the diversified holding company.

Rayner holds a unique position in the ophthalmic industry, having manufactured the world's first intraocular lens (IOL) in 1949.

It remains the sole manufacturer of IOLs in the UK, with state-of-the-art production facilities and global headquarters located in Worthing, England.

The company operates with a fast-paced and growing business model, employing over 900 individuals worldwide and selling its products in more than 80 countries globally through regional offices.

The acquisition is strategically driven by Rayner's established market leadership, its history of innovation in ophthalmic technology, and its robust global distribution network.

For GBL, this investment represents an opportunity to enter or expand its presence in the resilient and growing healthcare sector, particularly within the specialized field of ophthalmology.

GBL's financial backing and strategic oversight are expected to support Rayner's continued expansion and product development initiatives.

Expected synergies from this acquisition include leveraging GBL's extensive investment expertise and capital resources to accelerate Rayner's growth trajectory and enhance its global market penetration.

The combined entity is poised to further strengthen Rayner's position as a leading provider of cataract surgery solutions, fostering continued innovation and expanding its reach to more patients worldwide.